J.P. Morgan Healthcare Conference

Avanos Medical CEO Dave Pacitti will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13th. He will discuss the company’s strategic vision and innovations in medical devices, focusing on patient recovery, nutritional support, and reducing opioid reliance. Avanos aims to empower patients to regain mobility and return to fulfilling lives. The presentation will be webcast on the Avanos Medical website.

Molecular Partners will present pipeline updates and its 2025 outlook at the J.P. Morgan Healthcare Conference. CEO Patrick Amstutz will discuss advancements in their novel DARPin drug technology, focusing on oncology. The presentation, webcast live, is expected to detail clinical progress, strategic direction, and financial projections for the coming year, offering insights into the company’s innovative therapeutic approach and market potential.

Agilent Technologies will present at the J.P. Morgan Healthcare Conference on January 13, 2026. CEO Padraig McDonnell and CFO Adam Elinoff will share insights into the company’s strategic direction, financial performance, and innovation. The presentation, accessible via webcast, highlights Agilent’s role in life sciences, diagnostics, and applied chemical markets. With $6.95 billion in FY25 revenue and 18,000 employees, Agilent is a leader in analytical and clinical laboratory technologies, focusing on diagnostics, drug discovery, and environmental safety.